Healthcare Global Enterprises Ltd
Dr. V V B Iswarya Lakshmi is an experienced professional in the healthcare sector, currently serving as an Executive Business Analyst at Healthcare Global Enterprises Limited since September 2022. Prior to this role, Iswarya worked as a Six Sigma Project Intern at Tata Coffee, gaining expertise in applying analytical tools to identify cause and effect relationships. Previous experience includes a Business Analyst internship at EHNOTE, a Project Intern role at Apollo Hospitals, and a Sales and Business Development Intern position at Continental Hospitals, where Iswarya conducted interviews with doctors, wrote press releases, managed doctor profiles, and developed patient information leaflets. Iswarya is pursuing a Master's degree in Hospital Administration from Apollo Institute of Hospital Administration, having previously earned a Bachelor of Dental Surgery from Government Dental College and Hospital, Hyderabad.
This person is not in any teams
This person is not in any offices
Healthcare Global Enterprises Ltd
1 followers
HealthCare Global Enterprises Limited is engaged in managing cancer hospitals, cancer centers and medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. The Company is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. It operates cancer care network under the HCG brand. It operates infertility treatment clinics providing assisted reproductive services under brand Milann. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology, including molecular diagnostic services and genomic testing.